CeSPIACE: A broad spectrum peptide inhibitor against variable SARS-CoV-2 spikes
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
AZoLifeSciences on MSN4h
Bispecific antibodies for SARS-CoV-2 variant neutralization
Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...
How the pandemic changed the world of disease control for worse — and for better
Five years after the World Health Organization declared a global pandemic, there has been progress — and backsliding in the ...
Infectious Disease Advisor4h
COVID-19 mRNA-1273 Vaccine Highly Protective in Pediatric Patients After 2 Doses
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
First coronavirus similar to MERS discovered in bats in South America
A collaboration between researchers in the Brazilian states of São Paulo and Ceará and colleagues affiliated with Hong Kong ...
News-Medical.Net on MSN23h
COVID-19 discovery could open the door to new treatments for chronic lung diseases
University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to repair the lungs, helping explain the lingering effects of long COVID.